2m 2m 2m 2m 2m 2m 2m
Liquidia (LQDA)
NASDAQ
$69.25+$0.63 (+0.92%)
Price as of Aug 21, 2026 7:57 PM EDT- $6.1BMarket Cap
- 155.66%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Liquidia (LQDA)
$69.25+$0.63 (+0.92%)
LQDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $68.62 | ||
Change | -$2.43 (-3.42%) | ||
Open | $70.91 | ||
High | $71.13 | ||
Low | $68.05 | ||
Previous Close | $71.05 | ||
Volume | 1,700,916 | ||
30-Day Average Volume | 1,699,943 | ||
1-Week Change | -7.82% | ||
1-Month Change | -15.17% | ||
1-Year Change | 155.66% | ||
3-Year Change | 909.12% | ||
5-Year Change | 2,549.42% | ||
Fundamentals | |||
Shares Outstanding | 89.5M | ||
Total Assets | $521.9M | ||
Market Cap | $6.1B | ||
Enterprise Value | $5.9B | ||
Period: QTR TTM FY | |||
Revenue | $170.4M | ||
Net Income | $74.7M | ||
Free Cash Flow | $69.0M | ||
EBIT | $81.7M | ||
EBITDA | $82.1M | ||
Net Working Capital | $248.4M | ||
EPS | $0.74 | ||
Enterprise Value/EBITDA | 71 | ||
Enterprise Value/Revenue | 34 | ||
P/B | 31 | ||
P/E | 93 | ||
PEG | 2 | ||
Price/Free Cash Flow | 89 | ||
Price/Operating Cash Flow | 77 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue